Cancer Clinical Trials Make Comeback After Pandemic Slowdown
Deborah Doroshow, MD, PhD, discusses a study finding that the COVID-19 pandemic caused substantial disruption to clinical trials for cancer treatment and care.
Deborah Doroshow, MD, PhD, discusses a study finding that the COVID-19 pandemic caused substantial disruption to clinical trials for cancer treatment and care.